GO term enrichment analysis indicated that the most enriched upregulated gene signatures were associated with neuronal development, whereas downregulated genes were strongly associated with Erk1/2 signaling regulation (Fig. 5p), suggesting that inhibition of Erk signaling with SCH772984 may be a promising strategy to treat AD. The gene discussed is MAPK3; the disease is Alzheimer disease.